Fibroblast growth factor 5 as a target for atrial fibrillation treatment: Evidence from mendelian randomization

Previous studies have found that inflammatory proteins are involved in the pathogenesis of atrial fibrillation (AF). We used mendelian randomization to explore the potential pathogenic inflammatory proteins of AF.